![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
MAHOGANY: margetuximab in gastric cancer (VJOncology) View |
![]() |
MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEA (VJOncology) View |
![]() |
Margetuximab Along With Retifanlimab in High Expressing HER2+ Gastric Cancer (PracticeUpdate) View |
![]() |
Margetuximab for the Treatment of HER2+ Breast Cancer (Targeted Oncology) View |
![]() |
SOPHIA Trial in R/R HER2+ mBC (OncLive) View |
![]() |
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior ant... (ecancer) View |
![]() |
Antibody Drug Conjugates for Gastric Cancer (PracticeUpdate) View |
![]() |
Margetuximab Plus Pembrolizumab for Patients With HER2+ GE Junction Adenocarcinoma (PracticeUpdate) View |
![]() |
Practice-Changing Updates in the First-Line Treatment of Gastric/GEJ Cancer (1 of 2) (Practice Point Communications) View |
![]() |
Practice-Changing Updates in the First-Line Treatment of Gastric/GEJ Cancer (1 of 2) (Practice Point Communications) View |